Schrödinger (SDGR) Stock Could Be Undervalued On Its 67% Run
Schrödinger has had a sharp reset over the past year, and the rally puts a spotlight on a simple question for anyone looking at the stock today. Do the company’s actual and potential cash flows justify where the share price now sits? The stock has returned 67.4% over the past year, which raises the stakes on whether recent enthusiasm is fully backed by its cash generation prospects. Fresh progress in AI driven drug discovery and software adoption may support expectations for stronger future...
Schrödinger has had a sharp reset over the past year, and the rally puts a spotlight on a simple question for anyone looking at the stock today. Do the company’s actual and potential cash flows justify where the share price now sits? The stock has returned 67.4% over the past year, which raises the stakes on whether recent enthusiasm is fully backed by its cash generation prospects. Fresh progress in AI driven drug discovery and software adoption may support expectations for stronger future...
What's Your Reaction?
